News
The FDA expanded its approval of Moderna's RSV vaccine on Thursday to include adults under age 60 at increased risk of the ...
The U.S. Food and Drug Administration on Thursday expanded the use of Moderna's respiratory syncytial virus vaccine to a ...
The U.S. Food and Drug Administration extended the review of KalVista Pharmaceuticals' drug for a type of hereditary swelling ...
While it is not the most common allergy in the country, almost 2 million Americans have an allergy to soy, according to Food ...
The U.S. Food and Drug Administration on Thursday approved UroGen Pharma's drug to treat a type of bladder cancer, providing ...
Expanded indication builds on existing U.S. FDA approval of mRESVIA for adults aged 60 and older CAMBRIDGE, MA / ACCESS ...
Explore more
The federal government plans to develop a new definition of ultraprocessed foods, a wide-ranging group of snacks, meals and ...
To obtain full approval of the drug for treatment of chemotherapy-induced diarrhea (CID) and to expand the indication of ...
The Food and Drug Administration (FDA) expanded the approval of Moderna’s RSV vaccine late Thursday to include people 18 to ...
The FDA plans to "unleash AI" on new drug evaluations in order to "radically increase efficiency in the review process." ...
Learn more about the generative AI technology that will be used at the Food and Drug Administration (FDA) to speed up reviews ...
With a Trump-driven reduction of nearly 2,000 employees, agency officials view artificial intelligence as a way to speed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results